|Day Low/High||1.62 / 1.86|
|52 Wk Low/High||1.65 / 12.10|
BARDA Funded Preclinical Published in Stem Cell Research and Therapy
Updates on Other Selected Global Investigator Initiated Trials
A number of biotech-related stocks were down pre-market after announcing plans for public offerings.
Former hedge funder and biotech CEO Martin Shkreli finds himself in limbo as a criminal jury now decides if allegations of fraud will put him in orange coveralls.
Partnership to Launch at the EULAR (European League Against Rheumatism) Congress in Madrid, Spain June 14-17
Topline trial results announcement expected early Q3 2017
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.